Skip to the page

Data / Medical devices / United States / Millyard Advanced Medical Products LLC

Millyard Advanced Medical Products LLC: FDA-registered device maker in Manchester, NH, United States, 9 510(k) clearances

Millyard Advanced Medical Products LLC is registered with the FDA (registration 3016798778) in Manchester, NH, United States. It lists 8 device types. The FDA files 9 510(k) clearances under its listings, the newest dated August 1, 2025. Registered through 2027. FDA data exported November 3, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3016798778
Address
540 Commercial Street Suite 306, Manchester, NH, United States, 03101
Owner or operator
Millyard Advanced Medical Products LLC (10072764)
Roles
Complaint file establishment, Manufacturer
First device listed
May 1, 2020
Registered through
2027
Brand names listed
Remunity Pump for Remodulin (treprostinil) Injection, Remunity System, Remunity" Pump for Remodulin (treprostinil) Injection, Twiist Automated Insulin Delivery System, iiSure Infusion Set, twiist Automated Insulin Delivery System

Devices it lists

DeviceProduct codeClassRoleSource
Alternate Controller Enabled Insulin Infusion PumpQFG2Complaint file establishment, Manufactureraccessdata.fda.gov
Calculator, Drug DoseNDC2Complaint file establishment, Manufactureraccessdata.fda.gov
Controller, Infusion, Intravascular, ElectronicLDR2Complaint file establishment, Manufactureraccessdata.fda.gov
Infusion Pump, Drug Specific, Pharmacy-FilledQJY2Manufactureraccessdata.fda.gov
Insulin Pump Secondary DisplayPKU2Complaint file establishment, Manufactureraccessdata.fda.gov
Interoperable Automated Glycemic ControllerQJI2Complaint file establishment, Manufactureraccessdata.fda.gov
Pump, InfusionFRN2Complaint file establishment, Manufactureraccessdata.fda.gov
Set, Administration, IntravascularFPA2Complaint file establishment, Manufactureraccessdata.fda.gov

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
August 1, 2025K243841Sparta Infusion Set for InsulinFPASubstantially EquivalentDeka Research and Developmentaccessdata.fda.gov
April 2, 2025K250930twiist systemQFGSubstantially EquivalentDeka Research & Development Corp.accessdata.fda.gov
March 11, 2025K250357RemunityPRO™ Pump for Remodulin® (treprostinil) InjectionFRNSubstantially EquivalentDeka Research & Development Corp.accessdata.fda.gov
January 16, 2025K241736Remunity 2.0 Pump for Remodulin (treprostinil) InjectionFRNSubstantially EquivalentDeka Research and Development Corp.accessdata.fda.gov
November 27, 2024K243354Remunity SystemQJYSubstantially EquivalentDeka Research & Development Corp.accessdata.fda.gov
October 7, 2024K242693DEKA Infusion System, DEKA Administration SetLDRSubstantially EquivalentDeka Research and Development Corporationaccessdata.fda.gov
May 24, 2024K241178DEKA ACE Pump SystemQFGSubstantially EquivalentDeka Research and Developmentaccessdata.fda.gov
March 13, 2024K234055DEKA LoopQJISubstantially EquivalentDeka Research and Developmentaccessdata.fda.gov
February 21, 2020K191313Unity Subcutaneous Infusion System for RemodulinQJYSubstantially EquivalentDEKA Research & Developmentaccessdata.fda.gov

Compare with other makers

Updated August 1, 2025. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.